发明授权
US09126998B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
有权
氨基取代的咪唑并[1,2-a]吡啶甲酰胺及其用途
![Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use](/docs/US/2015-09-08/US09126998B2/abs.jpg.600x600.jpg)
- 专利标题： Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
- 专利标题（中）： 氨基取代的咪唑并[1,2-a]吡啶甲酰胺及其用途
-
申请号： US13789655申请日： 2013-03-07
-
公开(公告)号： US09126998B2公开(公告)日： 2015-09-08
- 发明人: Alexandros Vakalopoulos , Markus Follmann , Ingo Hartung , Philipp Buchgraber , Rolf Jautelat , Jorma Haβfeld , Niels Lindner , Frank Wunder , Johannes-Peter Stasch , Gorden Redlich , Volkhart Min-Jian Li , Eva-Maria Becker , Andreas Knorr
- 申请人： BAYER PHARMA AKTIENGESELLSCHAFT
- 申请人地址： DE Berlin
- 专利权人： BAYER PHARMA AG
- 当前专利权人： BAYER PHARMA AG
- 当前专利权人地址： DE Berlin
- 代理机构： Buchanan Ingersoll & Rooney
- 优先权： EP12191201 20121105
- 主分类号： A61K31/439
- IPC分类号： A61K31/439 ; A61K45/06 ; C07D471/04 ; A61K31/437 ; A61K31/496 ; A61K31/5377 ; A61K31/541 ; A61K31/4545 ; A61K31/46 ; A61K31/4709 ; A61K31/4725
![Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use](/abs-image/US/2015/09/08/US09126998B2/abs.jpg.150x150.jpg)
摘要：
The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
公开/授权文献
信息查询
IPC分类:
